The prospect of four new cancer medicines becoming a reality for patients has taken a huge step forward with the announcement of a £34M investment by a European private biotech company in University research.
Apr 11, 2014
0
0
Imaging probes that specifically target tumors can provide more sensitive and relevant information about the tumor compared to conventional, non-specific probes. Additionally, targeted probes can improve tumor detection, ...
May 5, 2016
0
3
Scientists from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and the Luxembourg Institute of Health (LIH) have recently demonstrated the mechanisms by which low oxygen ...
Dec 17, 2019
0
2
An international scientific team has successfully created a three-dimensional model of a cancerous tumour using a 3D printer. Their model could ultimately help discover new drugs and cast new light on how tumours develop, ...
May 27, 2015
0
7
Scientists at The University of Nottingham are tackling a tumour survival mechanism that has left experts baffled for more than 50 years.
Jun 28, 2017
0
2
Two Spanish university professors and three other suspects have been charged over the alleged sale of a "fake" cancer drug that raked in more than 600,000 euros, police said Tuesday.
Apr 11, 2017
0
1
The bacteria Staphylococcus aureus (S. aureus) can worsen the condition of patients with the lymphoma type Sezáry syndrome. A Danish research team has found an underlying mechanism. The improved understanding gives reason ...
Jan 16, 2024
0
0
A cell contains many specialized subunits, called organelles, that carry out important tasks such as energy generation, protein synthesis, and calcium outflux. But what happens when something goes wrong with one of the organelles?
Aug 31, 2023
0
0
A thesis at Umeå University shows that certain non-steroidal anti-inflammatory drugs, known as NSAIDs, can help patients who have undergone surgery for colorectal cancer. These patients suffer fewer recurrences of cancer ...
May 30, 2024
0
0
(HealthDay)—Cyramza (ramucirumab) has been approved by the U.S. Food and Drug Administration to treat cancer of the stomach or of the area where the esophagus joins the stomach (the gastroesophageal junction).
Apr 22, 2014
0
0
